Clinical trial
Continuous Ambulatory Cardiac Monitoring for Recurrent Atrial Fibrillation After Sepsis
NCT05217485 is registered in ClinicalTrials.gov with Cambridge University Hospitals NHS Foundation Trust as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Continuous Ambulatory Cardiac Monitoring for Recurrent Atrial Fibrillation After Sepsis
- Lead sponsor
- Cambridge University Hospitals NHS Foundation Trust
- Phase
- Not applicable
- Overall status
- Unknown status
- Start date
- March 31, 2022
- Completion date
- March 31, 2024
- Enrollment
- 125 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
atrial fibrillation, cardiac arrhythmia, infections, sepsis